Summary of notifiable diseases, United States 1996

Morbidity and Mortality Weekly Report

Volumn 45, Issue 53, 1997, Pages 1-103

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNICABLE DISEASE; HEALTH SURVEY; HUMAN; UNITED STATES;

COMMUNICABLE DISEASES; HUMANS; POPULATION SURVEILLANCE; UNITED STATES;

EID: 0031592897     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (158)

1. CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997; 46(No. RR-10).
2. CDC. Ten leading nationally notifiable infectious diseases - United States, 1995. MMWR 1996; 45:883-4.
3. CDC. Notifiable disease surveillance and notifiable disease statistics - United States, June 1946 and June 1996. MMWR 1996;45:530-7.
4. CDC. Manual of procedures for the reporting of nationally notifiable diseases to CDC. Atlanta: US Department of Health and Human Services, Public Health Service, CDC, 1995.
5. CDC. Sexually transmitted disease surveillance, 1993. Atlanta: US Department of Health and Human Services, Public Health Service, 1994.
6. CDC. Use of race and ethnicity in public health surveillance. MMWR 1993;42(No. RR-10).
7. CDC. National electronic telecommunications system for surveillance. Informational brochure July 1996.
8. CDC. Mandatory reporting of infectious diseases by clinicians, and mandatory reporting of occupational diseases by clinicians. MMWR 1990;39(No. RR-9).
9. Benenson AS. Control of communicable diseases in man. 16th ed. Washington, DC: American Public Health Association, 1995.
10. Koo D, Wetterhall S. History and current status of the National Notifiable Diseases Surveillance System. J Public Health Management and Practice 1996;2:4-10.
11. Martin SM, Bean NH. Data management issues for emerging diseases and new tools for managing surveillance and laboratory data. Emerging Infectious Diseases Journal 1995;1:124-8.
12. Teutsch SM, Churchill RE, eds. Principles and practice of public health surveillance. New York: Oxford University Press, 1994.
13. Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases. JAMA 1983;249: 1181-5.
14. Thacker SB, Stroup DF. Future directions for comprehensive public health surveillance and health information systems in the United States. Am J Epidemiol 1994;140:383-97.
15. CDC. HIV/AIDS surveillance report - Year-end edition. 1996;8(2).
16. CDC. AIDS among children - United States, 1996. MMWR 1996;1005-10.
17. CDC. Update: trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR 1997;165-73.
18. CDC. AIDS associated with injecting drug use - United States, 1995. MMWR 1996;392-8.
19. Brachman PS. Anthrax. In: Hoeprich PD, Jordan MC, Roland AR, eds. Infectious diseases. 5th ed. Philadelphia: JB Lippincott Co., 1994:1003-8.
20. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994;266:1202-8.
21. Monath TP, ed. The arboviruses: epidemiology and ecology. Boca Raton, FL: CRC Press, 1989. Tsai TF. Arboviral infections in the United States. Infect Dis Clin North Am 1991;5:73-102.
22. Tsai TF. Arboviruses and related zoonotic viruses. In: Oski FJ, ed. Principles and practices of pediatrics. 2nd ed. Philadelphia: JB Lippincott Co., 1994:1266-88.
23. Townes JM, Cieslak PR, Hatheway CL, et al. An outbreak of type A botulism associated with a commercial cheese sauce. Ann Intern Med 1996;125:558-63.
24. St. Louis ME, Peck SHS, Bowering D, et al. Botulism from chopped garlic: delayed recognition of a major outbreak. Ann Intern Med 1988;108:363-8.
25. Weber JT, Hatheway CL, St. Louis ME. Botulism. In: Hoeprich PD, Jordan MC, Ronald AR, eds. Infectious diseases: a treatise of infectious processes. 5th ed. Philadelphia: JB Lippincott Co., 1994:1185-94.
26. Woodruff BA, Griffin PM, McCroskey LM, et al. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States 1975-1988. J Infect Dis 1992;166:1281-6.
27. Chomel BB, DeBess EE, Mangiamele DM, et al. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J Infect Dis 1994;170:1216-23.
28. Kaufmann AF, Fox MD, Boyce JM, et al. Airborne spread of brucellosis. Ann NY Acad Sci 1980; 353:105-14.
29. Staskiewicz J, Lewis CM, Colville J, Zervos M, Band J. Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. J Clin Microbiol 1991;29:287-90.
30. CDC. Chancroid in the United States, 1981-1990: evidence for underreporting of cases. MMWR 1992;41(No. SS-3):57-61.
31. DiCarlo RP, Armentor BS, Martin DH. Chancroid epidemiology in New Orleans men. J Infect Dis 1995;172:446-52.
32. CDC. Chancroid detected by polymerase chain reaction - Jackson, Mississippi, 1994-1995. MMWR 1995;44:567,573-4.
33. CDC. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR 1993;42(RR-12):1-39.
34. Mosure DJ, Berman S, Kleinbaum D, Halloran ME. Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis. Amer J Epid 1996;144:997-1003.
35. Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ. Trends in the prevalence of chlamydial infections: the impact of community-wide testing. Sexually Transmitted Diseases 1997; 24:169-75.
36. CDC. Chlamydia trachomatis genital infections - United States, 1995. MMWR 1997;46:193-8.
37. Blake PA. Epidemiology of cholera in the Americas. Gastroenterol Clin North Am 1993;22:639-60.
38. Wachsmut h IK, Blake PA, Olsvik O, eds. Vibrio cholerae and cholera: molecular to global perspectives. Washington, DC: American Society for Microbiology, 1994.
39. World Health Organization. Guidelines for cholera control. Geneva: World Health Organization, 1993.
40. Mahon BE, Mintz ED, Greene KD, Wells JG, Tauxe RV. Reported cholera in the United States, 1992-1994: a reflection of global changes in cholera epidemiology. JAMA 1996;276:307-12.
41. Herwaldt BL, Ackers ML, Cyclospora Working Group. An outbreak in 1996 of cyclosporiasis associated with imported raspberries. N Engl J Med 1997;336:1548-56.
42. Huang P, Weber JT, Sosin DM, et al. The first reported outbreak of diarrheal illness associated with Cyclospora in the United States. Ann Intern Med 1995;123:409-14.
43. CDC. Update: Outbreaks of Cyclospora cayetenensis infections - United States and Canada, 1996. MMWR 1997;46:521-3.
44. Soave R. Cyclospora: an overview. Clin Infect Dis 1996;23:429-35.
45. Juranek DD. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin Infect Dis 1995;21(suppl. 1):S57-S61.
46. CDC. Assessing the public health threat associated with waterborne cryptosporidiosis: report of a workshop. MMWR 1995;44(No. RR-6):1-19.
47. Kramer MH, Herwaldt BL, Craun GF, Calderon RL, Juranek DD. Surveillance for waterborne-disease outbreaks - United States, 1993-1994. MMWR 1996;45(No. SS-1).
48. Rigau-Perez JG, Gubler DJ, Vorndam AV, Clark GG. Dengue in travelers from the United States, 1986-1994. J Travel Med 1997;4:65-71.
49. CDC. Diphtheria acquired by U.S. citizens in the Russian Federation and Ukraine - 1994. MMWR 1995;44:237,243-4.
50. CDC. Status report on the Childhood Immunization Initiative: reported cases of selected vaccine-preventable diseases - United States, 1996. MMWR 1997;46:665-71.
51. Hardy IRB, Dittmann S, Sutter RW. Resurgence of diphtheria in the New Independent States of the former Soviet Union: current situation and control strategies. Lancet 1996;347:1739-44.
52. Boyce TG, Pemberton AG, Wells JG, Griffin PM. Screening for Escherichia coli O157:H7 - a nationwide survey of clinical laboratories. J Clin Microbiol 1995;33:3275-7.
53. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E.coli and the associated hemolytic uremic syndrome. Epidemiol Rev 1991;13:60-98.
54. Martin DL, MacDonald KL, White KE, Soler JT, Osterholm MT. The epidemiology and clinical aspects of the hemolytic-uremic syndrome in Minnesota. N Engl J Med 1990;323:1161-7.
55. Slutsker L, Ries AA, Greene KD, et al. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 1997;126:505-13.
56. CDC. Surveillance for gonorrhea and primary and secondary syphilis among adolescents -United States, 1981-1991. MMWR 1993;42(No. SS-3):1-11.
57. CDC. Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae - United States, 1988-1991. MMWR 1993;42(No. SS-3):29-39.
58. CDC. Fluoroquinolone resistance in Neisseria gonorrhoeae - Colorado and Washington, 1995. MMWR 1995;44:762-4.
59. Gershman KA, Barrow JC. A tale of two sexually transmitted diseases: prevalences and predictors of chlamydia and gonorrhea in women attending Colorado family planning clinics. Sexually Transmitted Diseases 1996;23:481-8.
60. CDC. Hantavirus infection - Southwestern United States: interim recommendations for risk reduction. MMWR 1993;42(No. RR-11):1-12.
61. Khan AS, Khabbaz RF, Armstrong LR, et al. Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis 1996;173:1297-303.
62. Khan AS, Ksiazek TG, Peters CJ. Hantavirus pulmonary syndrome. Lancet 1996;347:739-41.
63. CDC. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1993;42(No. RR-13).
64. Adams WG, Keaver KA, Cochi SL, etal. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
65. CDC. Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1993-1994. MMWR 1995;44:545-50.
66. Urwin G, Krohn JA, Deaver-Robinson K, et al. Invasive disease due to Haemophilus influenzae serogroup f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. Clin Inf Dis 1996;22:1069-76.
67. Mastro TD, Redd SC, Breiman RF. Imported leprosy in the United States, 1978 through 1988: an epidemic without secondary transmission. Am J Public Health 1992;82:1127-30.
68. Noordeen SK. Epidemiology and control of leprosy - a review of progress over the last 30 years. Trans R Soc Trop Med Hyg 1993;87:515-7.
69. Smith PG. Recent trends in the epidemiology of tuberculosis and leprosy. Trop Geogr Med 1991 July;43(suppl. 3):S22-S29.
70. Alter MJ, Mares A, Hadler SC, Maynard JE. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol 1987;125:133-9.
71. CDC. Hepatitis surveillance report no. 56. Atlanta, GA: US Department of Health and Human Services, Public Health Service, 1996.
72. Shapiro CN, Coleman PJ, McQuillan GM, et al. Epidemiology of hepatitis A: seroepidemiology and risk groups in the U.S.A. Vaccine 1992;10(suppl. 1):S59-S62.
73. Lemon SM, Shapiro CN. The value of immunization against hepatitis A. Infectious Agents and Disease 1994;1:38-49.
74. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991;11:84-92.
75. Alter MJ. Epidemiology of hepatitis C in the West. Seminars in Liver Disease 1995;15:5-14.
76. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-905.
77. Jernigan DB, Hofmann J, Cetron MS, et al. Outbreak of Legionnaires' disease among cruise ship passengers exposed to a contaminated whirlpool spa. Lancet 1996;347:494-9.
78. Keller DW, Hajjeh R, DeMaria A Jr, et al. Community outbreak of legionnaires' disease: an investigation confirming the potential for cooling towers to transmit legionella species. Clin Infect Dis 1996;22:257-61.
79. Marston BJ, Lipman HB, Breiman RF. Surveillance for legionnaires' disease: risk factors for morbidity and mortality. Arch Intern Med 1994;154:2417-22.
80. Miller LA, Beebe JL, Butler JC, et al. Use of polymerase chain reaction in an epidemiologic investigation of Pontiac fever. J Infect Dis 1993;168:769-72.
81. CDC. Lyme disease - United States, 1996. MMWR 1997;46:531-5.
82. CDC. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR 1995;44:590-1.
83. Dennis DT. Lyme disease. Dermatologic Clinics 1995;13:537-51.
84. CDC. Local transmission of Plasmodium vivax malaria - Houston, Texas, 1994. MMWR 1994; 44:295.
85. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993;341:848-51.
86. Zucker JR, Campbell CC. Malaria: principles of prevention and treatment. Infect Dis Clin North Am 1993;7:547-67.
87. CDC. Measles prevention: recommendations of the Immunization Practices Advisory Committee. MMWR 1989;38(No. SS-9):1-18.
88. CDC. Measles - United States, 1996. MMWR 1997;46:242-6.
89. CDC. Measles - United States, 1995. MMWR 1996;45:305-7.
90. CDC. Laboratory-based surveillance for meningococcal disease in selected areas - United States, 1989-1991. MMWR 1993;42(No. SS-2):21-30.
91. CDC. Control and prevention of meningococcal disease and control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46 (No. RR-5).
92. CDC. Serogroup Y meningococcal disease - Illinois, Connecticut, and selected areas, United States, 1989-1996. MMWR 1996;45:1010-3.
93. Fischer M, Perkins BA. Neisseria meningitidis serogroup B: emergence of the ET-5 complex. Sem Pediatr Infect Dis 1997;8:50-6.
94. Briss PA, Fehrs LJ, Parker RA, et al. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 1994;169:77-82.
95. CDC. Mumps prevention. MMWR 1989;38:388-92,397-400.
96. CDC. Mumps surveillance - United States, 1988-1993. MMWR 1995;44(No. SS-3):1-14.
97. Hersch BS, Fine PEM, Kent WK, et al. Mumps outbreak in a highly vaccinated population. J Pediatr 1991;119:187-93.
98. CDC. Pertussis - United States, January 1992-June 1995. MMWR 1995;44:525-9.
99. CDC. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(No. RR-7):1-25.
100. Guris D, Strebel PM, Tachdjian R, Bardenheier B, Wharton M, Hadler SC. Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994. J Inf Dis 1997;176.
101. Craven RB, Barnes AM. Plague and tularemia. Infect Dis Clin North Am 1991;5:165-75.
102. Poland JD, Quan TJ, Barnes AM. Plague. In: Beran GW, ed. CRC handbook series in zoonoses: section A - bacterial , rickettsial and mycotic diseases. Boca Raton, FL: CRC Press, Inc., 1994;93-112.
103. CDC. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(No. RR-3):1-25.
104. CDC. Paralytic poliomyelitis - United States, 1980-1994. MMWR 1997;46:79-83.
105. Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Arch Pediatr Ado lese Med 1994;148:479-85.
106. Strebel PM, Sutter RW, Cochi SL, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 1992;14:568-79.
107. CDC. Human psittacosis linked to a bird distributor in Mississippi - Massachusetts and Tennessee, 1992. MMWR 1992;41:794-7.
108. Jorgensen DM. Gestational psittacosis in a Montana sheep rancher. Emerg Infect Dis 1997; 3:191-4.
109. National Association of State Public Health Veterinarians. Compendium of chlamydiosis (psittacosis) control, 1995. JAVMA 1995;206:1874-9.
110. Wong KH, Skelton SK, Daugharty H. Utility of complement fixation and microimmunofluorescence assays for detecting serologic responses in patients with clinically diagnosed psittacosis. J Clin Microbiol 1994;32:2417-21.
111. CDC. Compendium of animal rabies control, 1997. MMWR 1997;46(No. RR-4).
112. CDC. Rabies prevention - United States, 1991: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(No. RR-3).
113. Krebs JW, Strine TW, Smith JS, Noah DL, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 1995. JAVMA 1996;209:2031-44.
114. Dalton MJ, Clarke MJ, Holman RC, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995;52:405-13.
115. Woodward TE. Rocky Mountain spotted fever: epidemiological and early clinical signs are keys to treatment and reduced mortality. J Infect Dis 1984;150:465-8.
116. Salgo MP, Telzak EE, Currie B, et al. A focus of Rocky Mountain spotted fever within New York City. N Engl J Med 1988;318:1345-8.
117. CDC. Rubella prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1990;39(No. RR-15).
118. CDC. Outbreaks of rubella among the Amish - United States, 1991. MMWR 1991;40:264.
119. CDC. Rubella and congenital rubella syndrome - United States, January 1, 1991-May 7, 1994. MMWR 1994;43:391,397-401.
120. Lindegren ML, Fehrs LJ, Hadler SC, Hinman AR. Update: rubella and congenital rubella syndrome, 1980-1990. Epidemiol Rev 1991;13:341-8.
121. Mahon BE, Pönkä A, Hall WN, et al. An international outbreak of Salmonella infections caused by alfalfa sprouts grown from contaminated seeds. J Infect Dis 1997;175:876-82.
122. Mermin J, Hoar B, Angulo FJ. Iguanas and Salmonella Marina infection in children: a reflection of the incidence of reptile-associated salmonellosis in the United States. Pediatrics 1997;99:399-402.
123. CDC. Multidrug-resistant Salmonella serotype Typhimurium - United States, 1996. MMWR 1997; 46:308-10.
124. Hennessy TW, Hedberg CW, Slutsker L, et al. A national outbreak of Salmonella enteritidis infections from ice cream. New Engl J Med 1996;334:1281-6.
125. CDC. Outbreaks of Salmonella serotype Enteritidis infection associated with consumption of raw shell eggs - United States, 1994-1995. MMWR 1996;45:737-42.
126. Lee LA, Shapiro CN, Hargrett-Bean N, Tauxe RV. Hyperendemic shigellosis in the United States: a review of surveillance data for 1967-1988. J Infect Dis 1991;164:894-900.
127. Mohle-Boetani JC, Stapleton M, Finger R, et al. Communitywide shigellosis: control of an out-break and risk factors in child day-care centers. Am J Public Health 1995;85:812-6.
128. Parsonnet J, Greene KD, Gerber AR, et al. Shigella dysenteriae type 1 infections in U.S. travelers to Mexico. Lancet 1989:543-5.
129. Ries AA, Wells JG, Olivola D, et al. Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention. J Infect Dis 1994;169:1035-41.
130. Thomas JC, Kulik AL, Schoenbach VJ. Syphilis in the south: rural rates in North Carolina. Am J Public Health 1995;85:1119-22.
131. St. Louis ME, Farley TA, Aral SO. Untangling the persistence of syphilis in the south. Sex Transm Dis 1996;23:1-4.
132. Nakashima AK, Rolfs RT, Flock ML, Kilmarx P, Greenspan JR. Epidemiology of syphilis in the United States, 1941-1993. Sex Transm Dis 1996;23:16-23.
133. CDC. Outbreak of primary and secondary syphilis - Baltimore City, Maryland, 1995. MMWR 1996;45:166-9.
134. CDC. Guidelines for the prevention and control of congenital syphilis. MMWR 1988;37(No. S-1): 1-13.
135. CDC. Surveillance for geographic and secular trends in congenital syphilis - United States, 1983-1991. MMWR 1993;42(No. SS-6):59-71.
136. Coles BF, Hipp SS, Silberstein GS, Chen JH. Congenital syphilis surveillance in upstate New York, 1989-1992: implications for prevention and clinical management. J Infect Dis 1995;171:732-5.
137. Risser WL, Hwang LY. Problems in the current case definitions of congenital syphilis. J Pediatr 1996;129:499-505.
138. Izurieta HS, Sutter RW, Strebel PM, et al. Tetanus surveillance - United States 1991-1994. MMWR 1997;46(No. SS-2):15-25.
139. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995;332:761-6.
140. Prevots R, Sutter R, Strebel PM, Cochi S, Hadler S. Tetanus surveillance - United States, 1989-1990. MMWR 1992;41(No. SS-8):1-9.
141. Sutter RW, Cochi SL, Brink EW, Sirotkin BI. Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984. Am J Epidemiol 1990;131:132-42.
142. CDC. Reduced incidence of menstrual toxic shock syndrome - United States, 1980-1990. MMWR 1990;39:421-3.
143. Gaventa S, Reingold AL, Hightower AW, et al. Active surveillance for toxic shock syndrome in the United States, 1986. Rev Infect Dis 1989;11(suppl.):S28-S34.
144. Schuchat A, Broome CV. Toxic shock syndrome and tampons. Epidemiol Rev 1991;13:99-112.
145. CDC. Trichinosis surveillance - United States, 1987-1990. MMWR 1991;40(No. SS-3):35-42.
146. McAuley JB, Michelson MK, Hightower AW, Engeran S, Wintermeyer LA, Schantz PM. A trichinosis outbreak among Southeast Asian refugees. Am J Epidemiol 1992;135:1404-10.
147. CDC. Outbreak of trichinellosis associated with eating cougar jerky - Idaho, 1995. MMWR 1996; 45:205-6.
148. Schantz PM, Moore AC, Munoz JM, et al. Neurocysticercosis in an orthodox Jewish community in New York City. N Engl J Med 1992;327:692-5.
149. American Thoracic Society, CDC. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-74.
150. CDC. Recommendations for counting reported tuberculosis cases. In: Reported tuberculosis in the United States, 1996. July 1997:61-8.
151. CDC. Tuberculosis morbidity - United States, 1996. MMWR 1997;46:695-700.
152. CDC. Typhoid immunization: recommendations of the Advisory Committee on Immunization Practices. MMWR 1994;43(No. RR-14).
153. Woodruff BA, Pavia AT, Blake PA. A new look at typhoid vaccination: information for the practicing physician. JAMA 1991;265:756-9.
154. Mermin JH, Townes JM, Gerber M, Dolan N, Mintz ED, Tauxe RV. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. Arch Inter Med 1997 (in press).
155. CDC. Varicella-related deaths among adults - United States, 1997. MMWR 1997;46:409-12.
156. CDC. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(No. RR-11):1-36.
157. Plotkin, SA. Varicella vaccine [Commentary]. Pediatrics 1996;97:251-3.
158. White CJ. Varicella-zoster virus vaccine. Clin Infect Dis 1997;24:753-63.